Ashiru, O.; Esteso, G.; García‐Cuesta, E.M.; Castellano, E.; Samba, C.; Escudero-López, E.; López‐Cobo, S.; Álvarez-Maestro, M.; Linares, A.; Ho, M.M.;
et al. BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine. Cancers 2019, 11, 940.
https://doi.org/10.3390/cancers11070940
AMA Style
Ashiru O, Esteso G, García‐Cuesta EM, Castellano E, Samba C, Escudero-López E, López‐Cobo S, Álvarez-Maestro M, Linares A, Ho MM,
et al. BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine. Cancers. 2019; 11(7):940.
https://doi.org/10.3390/cancers11070940
Chicago/Turabian Style
Ashiru, Omodele, Gloria Esteso, Eva M. García‐Cuesta, Eva Castellano, Celia Samba, Eva Escudero-López, Sheila López‐Cobo, Mario Álvarez-Maestro, Ana Linares, Mei M. Ho,
and et al. 2019. "BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine" Cancers 11, no. 7: 940.
https://doi.org/10.3390/cancers11070940
APA Style
Ashiru, O., Esteso, G., García‐Cuesta, E. M., Castellano, E., Samba, C., Escudero-López, E., López‐Cobo, S., Álvarez-Maestro, M., Linares, A., Ho, M. M., Leibar, A., Martínez‐Piñeiro, L., & Valés‐Gómez, M.
(2019). BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine. Cancers, 11(7), 940.
https://doi.org/10.3390/cancers11070940